Expansion of Escherichia-Shigella in Gut Is Associated with the Onset and Response to Immunosuppressive Therapy of IgA Nephropathy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expansion of Escherichia-Shigella in Gut Is Associated with the Onset and Response to Immunosuppressive Therapy of IgA Nephropathy
Authors
Keywords
-
Journal
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume -, Issue -, Pages ASN.2022020189
Publisher
American Society of Nephrology (ASN)
Online
2022-08-30
DOI
10.1681/asn.2022020189
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Live Combined Bacillus subtilis and Enterococcus faecium on Gut Microbiota Composition in C57BL/6 Mice and in Humans
- (2022) Xionge Pi et al. Frontiers in Cellular and Infection Microbiology
- Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review
- (2021) Jin Zhao et al. RENAL FAILURE
- Integrated Fecal Microbiome and Serum Metabolomics Analysis Reveals Abnormal Changes in Rats with Immunoglobulin A Nephropathy and the Intervention Effect of Zhen Wu Tang
- (2021) Jicheng Li et al. Frontiers in Pharmacology
- Associations of Genetic Variants Contributing to Gut Microbiota Composition in Immunoglobin A Nephropathy
- (2021) Jia-Wei He et al. mSystems
- Identification of a novel interplay between intestinal bacteria and metabolites in Chinese patients with IgA nephropathy via integrated microbiome and metabolome approaches
- (2021) Hongwei Wu et al. Annals of Translational Medicine
- Acetate Downregulates the Activation of NLRP3 Inflammasomes and Attenuates Lung Injury in Neonatal Mice With Bronchopulmonary Dysplasia
- (2021) Qian Zhang et al. Frontiers in Pediatrics
- Gut microbiota in Immunoglobulin A Nephropathy: a Malaysian Perspective
- (2021) Agni Nhirmal Kumar Sugurmar et al. BMC Nephrology
- Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy
- (2021) Wai Han Yiu et al. Frontiers in Physiology
- Rifaximin as a Potential Treatment for IgA Nephropathy in a Humanized Mice Model
- (2021) Vincenzo Di Leo et al. Journal of Personalized Medicine
- Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy
- (2021) Lingxiong Chai et al. BMC Nephrology
- The mucosal immune system and IgA nephropathy
- (2021) Loreto Gesualdo et al. Seminars in Immunopathology
- Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy
- (2021) Gabriella Lauriero et al. Frontiers in Immunology
- Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells
- (2020) Elizabeth C. Rosser et al. Cell Metabolism
- A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn’s Disease in Remission
- (2020) Zhengxiao Zhang et al. Journal of Crohns & Colitis
- Ammonia induce lung tissue injury in broilers by activating NLRP3 inflammasome via Escherichia/Shigella
- (2020) Qing Xiu Liu et al. POULTRY SCIENCE
- Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study
- (2020) Xiaofang Hu et al. BMC Nephrology
- Kuijieyuan Decoction Improved Intestinal Barrier Injury of Ulcerative Colitis by Affecting TLR4-Dependent PI3K/AKT/NF-κB Oxidative and Inflammatory Signaling and Gut Microbiota
- (2020) Baohai Liu et al. Frontiers in Pharmacology
- The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice
- (2020) Xueyang Li et al. Gut Microbes
- Diet posttranslationally modifies the mouse gut microbial proteome to modulate renal function
- (2020) Lior Lobel et al. SCIENCE
- A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy
- (2020) Ruijuan Dong et al. Frontiers in Cellular and Infection Microbiology
- Alterations of the Human Gut Microbiome in Chronic Kidney Disease
- (2020) Zhigang Ren et al. Advanced Science
- Mitochondrial dysfunction caused by outer membrane vesicles from Gram-negative bacteria activates intrinsic apoptosis and inflammation
- (2020) Pankaj Deo et al. Nature Microbiology
- Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population
- (2020) ZhengXia Zhong et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- High levels of gut-homing immunoglobulin A–positive+B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients
- (2020) Fabio Sallustio et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Chemotaxis-selective colonization of mangrove rhizosphere microbes on nine different microplastics
- (2020) Huifeng Xie et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1
- (2019) Dana V. Rizk et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of Lubiprostone on Urinary Protein Excretion: A Report of Two IgA Nephropathy Patients with Chronic Constipation
- (2019) Mitsuhide Takeshita et al. INTERNAL MEDICINE
- Rarefaction, Alpha Diversity, and Statistics
- (2019) Amy D. Willis Frontiers in Microbiology
- The impact of food additives, artificial sweeteners and domestic hygiene products on the human gut microbiome and its fibre fermentation capacity
- (2019) Konstantinos Gerasimidis et al. EUROPEAN JOURNAL OF NUTRITION
- The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
- (2018) Tao Yang et al. Nature Reviews Nephrology
- β-Diversity, Community Assembly, and Ecosystem Functioning
- (2018) Akira S. Mori et al. TRENDS IN ECOLOGY & EVOLUTION
- OUP accepted manuscript
- (2018) NEPHROLOGY DIALYSIS TRANSPLANTATION
- Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
- (2017) Bengt C Fellström et al. LANCET
- KEGG: new perspectives on genomes, pathways, diseases and drugs
- (2016) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Intestinal Microbiota Modulates Gluten-Induced Immunopathology in Humanized Mice
- (2015) Heather J. Galipeau et al. AMERICAN JOURNAL OF PATHOLOGY
- Gluten exacerbates IgA nephropathy in humanized mice through gliadin–CD89 interaction
- (2015) Christina Papista et al. KIDNEY INTERNATIONAL
- Proteobacteria: microbial signature of dysbiosis in gut microbiota
- (2015) Na-Ri Shin et al. TRENDS IN BIOTECHNOLOGY
- Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN)
- (2014) Maria De Angelis et al. PLoS One
- KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis
- (2013) Laurence Beck et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Novel role of PKR in inflammasome activation and HMGB1 release
- (2012) Ben Lu et al. NATURE
- Mice overexpressing BAFF develop a commensal flora–dependent, IgA-associated nephropathy
- (2011) Douglas D. McCarthy et al. JOURNAL OF CLINICAL INVESTIGATION
- The Pathophysiology of IgA Nephropathy
- (2011) H. Suzuki et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
- (2009) P. D. Schloss et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started